Effect of Murine Interferon Alpha/beta on Tumour-induced Suppressor Function

Overview

Journal Cancer Immunol Immunother

Specialties Allergy & Immunology
Oncology
Pharmacology

Date 1994 Dec 1

PMID 8001023

Citations 2

Authors

D M Sahasrabudhe

J C Dusel

Affiliations

Soon will be listed here.

Abstract

T-lymphocyte-mediated immunosuppression has been described in several animal models and in man. In animal models. T-cell-mediated immunosuppression can hasten the development of cancers, permit the growth of tumors in immunocompetent hosts, and inhibit otherwise effective antitumor immunotherapy. Cyclophosphamide can abrogate the T-cell-mediated immunosuppression. However, inappropriately administered cyclophosphamide can adversely affect antitumor immunity. On the basis of data showing that interferon alpha/beta (IFN alpha/beta) and IFN beta selectively abrogate the T-cell-mediated dinitrofluorobenzene-specific suppressor function, we investigated the efficacy of purified murine IFN alpha/beta in manipulating tumor-induced T-cell-mediated immunosuppression in the well-characterized P815 mastocytoma model. In this model, generation of cytotoxicity in vitro and its inhibition by T cells correlates with antitumor immunity in vivo. We report that IFN alpha/beta selectively diminishes the generation of tumor-induced suppressor activity.

Citing Articles

The Use of Registries to Improve Cancer Treatment: A National Database for Patients Treated with Interleukin-2 (IL-2).

Kaufman H, Wong M, Daniels G, Mcdermott D, Aung S, Lowder J J Pers Med. 2015; 4(1):52-64.

PMID: 25562142 PMC: 4251407. DOI: 10.3390/jpm4010052.

Failure of tumor-reactive lymph node cells to kill tumor in the presence of immune-suppressive CD34+ cells can be overcome with vitamin D3 treatment to diminish CD34+ cell levels.

Wiers K, Wright M, Vellody K, Young M Clin Exp Metastasis. 1998; 16(3):275-82.

PMID: 9568645 DOI: 10.1023/a:1006501110857.

References

Nakauchi H, Ohno I, Kim M, Okumura K, Tada T . Establishment and functional analysis of a cloned, antigen-specific suppressor effector T cell line. J Immunol. 1984; 132(1):88-94. View

Roberts L . Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses. J Immunol. 1986; 136(5):1908-16. View

Shaw A, Chan J, Reid S, Seehafer J . HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta. J Natl Cancer Inst. 1985; 74(6):1261-8. View

Dennert G, HYMAN R, Lesley J, Trowbridge I . Effects of cytotoxic monoclonal antibody specific for T200 glycoprotein on functional lymphoid cell populations. Cell Immunol. 1980; 53(2):350-64. DOI: 10.1016/0008-8749(80)90335-4. View

Jenkins M, Miller S . Immunoregulatory pathways in adult responder mice. III. Establishment of a GAT-specific suppressor T cell clone from GAT-tolerant responders which afferently regulates DTH responses. J Mol Cell Immunol. 1985; 2(1):1-13. View

Heuer J, Bruner K, Opalka B, Kolsch E . A cloned T-cell line from a tolerant mouse represents a novel antigen-specific suppressor cell type. Nature. 1982; 296(5856):456-9. DOI: 10.1038/296456a0. View

Trotta P . Preclinical biology of alpha interferons. Semin Oncol. 1986; 13(3 Suppl 2):3-12. View

Ledbetter J, Herzenberg L . Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev. 1979; 47:63-90. DOI: 10.1111/j.1600-065x.1979.tb00289.x. View

Yamamura M, Uyemura K, Deans R, Weinberg K, Rea T, Bloom B . Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science. 1991; 254(5029):277-9. DOI: 10.1126/science.254.5029.277. View

10.

NORTH R . Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells. J Exp Med. 1986; 164(5):1652-66. PMC: 2188446. DOI: 10.1084/jem.164.5.1652. View

11.

Dye E, NORTH R . Adoptive immunization against an established tumor with cytolytic versus memory T cells. Immediate versus delayed onset of regression. Transplantation. 1984; 37(6):600-5. DOI: 10.1097/00007890-198406000-00015. View

12.

Salgame P, Abrams J, Clayberger C, Goldstein H, Convit J, Modlin R . Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 1991; 254(5029):279-82. DOI: 10.1126/science.254.5029.279. View

13.

Rich S, Carpino M, Arhelger C . Suppressor T cell growth and differentiation. Identification of a cofactor required for suppressor T cell function and distinct from interleukin 2. J Exp Med. 1984; 159(5):1473-90. PMC: 2187293. DOI: 10.1084/jem.159.5.1473. View

14.

Sy M, Miller S, Moorhead J, Claman H . Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen. J Exp Med. 1979; 149(5):1197-207. PMC: 2184869. DOI: 10.1084/jem.149.5.1197. View

15.

FISHER M, Kripke M . Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science. 1982; 216(4550):1133-4. DOI: 10.1126/science.6210958. View

16.

Knop J, Stremmer R, Taborski U, Freitag W, De Maeyer-Guignard J, Macher E . Inhibition of the T suppressor circuit of delayed-type hypersensitivity by interferon. J Immunol. 1984; 133(5):2412-6. View

17.

Dye E, NORTH R . Specificity of the T cells that mediate and suppress adoptive immunotherapy of established tumors. J Leukoc Biol. 1984; 36(1):27-37. DOI: 10.1002/jlb.36.1.27. View

18.

Liew F . Specific suppression of responses to Leishmania tropica by a cloned T-cell line. Nature. 1983; 305(5935):630-2. DOI: 10.1038/305630a0. View

19.

Sahasrabudhe D, McCune C, ODonnell R, HENSHAW E . Inhibition of suppressor T lymphocytes (Ts) by cimetidine. J Immunol. 1987; 138(9):2760-3. View

20.

Dialynas D, Wilde D, Marrack P, Pierres A, Wall K, Havran W . Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity. Immunol Rev. 1983; 74:29-56. DOI: 10.1111/j.1600-065x.1983.tb01083.x. View